雇员点评标签
职位描述
化学药
Role Overview
This is a high-impact technical leadership role designed for an experience analytical scientist with a proven track record of working in a cGMP environment with deep expertise in ADC, monoclonal antibodies, bispecific antibodies, recombinant proteins, and fusion proteins, etc. As QC’s subject matter expert (SME), this position will serve as the technical bridge between QC /AD and between QC/global clients, leading complex investigations, and driving technical client communications.
Key Responsibilities
1. Technical Leadership & Complex Investigations (50%)
Serve as the technical lead for OOS/OOT/OOE investigations involving product-specific CQAs for both DS/DP release and stability testing.
Provide deep technical input for troubleshooting for any atypical results investigation, including method performance issues (during method transfer and post-transfer), instrument anomalies, and product-related degradation pathways.
For ADC programs: Lead investigation of DAR (drug-to-antibody ratio), unconjugated antibody, aggregation post-conjugation, and payload-related impurity issues, and stability related events.
Complex problem-solving capabilities: Ability to evaluate the totality of data and integrate data from multiple sources to identify root causes that are not immediately obvious. Comfortable leading investigations where the path forward is unclear.
2. Client-Facing & Regulatory Communication (30%)
Lead technical presentations (data packages, method validation summaries, investigation reports,etc) for global pharma clients (US/EU) in English, with the ability to adapt communication style for different audiences.
Draft and defend responses to client audit findings as well as regulatory authorities inspection observations.
Act as the primary QC technical spokesperson during client audits and regulatory inspections. This includes the ability to think on your feet during live questioning and respond to challenging technical inquiries with poise and accuracy.
Complex communication capabilities: Ability to explain a major OOS or deviation event related to testing to oversea client in a way that builds trust rather than causing panic – balancing full transparency with scientific rationale and a clear path forward. Comfortable leading difficult conversations where bad news must be delivered constructively.
3. Cross-Functional Technical Integration (20%)
Partner with AD to ensure seamless method transfer from development to QC.
Provide technical oversight for data integrity (21 CFR Part 11, audit trail review) of analytical computerized systems (e.g., Empower, SoftMax Pro, etc).
Support comparability studies (pre- and post-process change, site transfer) with robust statistical and analytical analysis.
Qualifications
Education:
Master‘s degree (required) or PhD (strongly preferred) in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences, or related field from oversea university (US preferred).
Experience:
Minimum 5+ years (PhD) or 8+ years (Master) of hands-on analytical experience in biologics CMC within a multinational corporation (MNC), oversea working experience is strongly preferred.
Proven track record of working in an English-speaking work environment (US/EU) – must demonstrate ability to lead scientific discussions in English without language barriers.
This is a high-impact technical leadership role designed for an experience analytical scientist with a proven track record of working in a cGMP environment with deep expertise in ADC, monoclonal antibodies, bispecific antibodies, recombinant proteins, and fusion proteins, etc. As QC’s subject matter expert (SME), this position will serve as the technical bridge between QC /AD and between QC/global clients, leading complex investigations, and driving technical client communications.
Key Responsibilities
1. Technical Leadership & Complex Investigations (50%)
Serve as the technical lead for OOS/OOT/OOE investigations involving product-specific CQAs for both DS/DP release and stability testing.
Provide deep technical input for troubleshooting for any atypical results investigation, including method performance issues (during method transfer and post-transfer), instrument anomalies, and product-related degradation pathways.
For ADC programs: Lead investigation of DAR (drug-to-antibody ratio), unconjugated antibody, aggregation post-conjugation, and payload-related impurity issues, and stability related events.
Complex problem-solving capabilities: Ability to evaluate the totality of data and integrate data from multiple sources to identify root causes that are not immediately obvious. Comfortable leading investigations where the path forward is unclear.
2. Client-Facing & Regulatory Communication (30%)
Lead technical presentations (data packages, method validation summaries, investigation reports,etc) for global pharma clients (US/EU) in English, with the ability to adapt communication style for different audiences.
Draft and defend responses to client audit findings as well as regulatory authorities inspection observations.
Act as the primary QC technical spokesperson during client audits and regulatory inspections. This includes the ability to think on your feet during live questioning and respond to challenging technical inquiries with poise and accuracy.
Complex communication capabilities: Ability to explain a major OOS or deviation event related to testing to oversea client in a way that builds trust rather than causing panic – balancing full transparency with scientific rationale and a clear path forward. Comfortable leading difficult conversations where bad news must be delivered constructively.
3. Cross-Functional Technical Integration (20%)
Partner with AD to ensure seamless method transfer from development to QC.
Provide technical oversight for data integrity (21 CFR Part 11, audit trail review) of analytical computerized systems (e.g., Empower, SoftMax Pro, etc).
Support comparability studies (pre- and post-process change, site transfer) with robust statistical and analytical analysis.
Qualifications
Education:
Master‘s degree (required) or PhD (strongly preferred) in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences, or related field from oversea university (US preferred).
Experience:
Minimum 5+ years (PhD) or 8+ years (Master) of hands-on analytical experience in biologics CMC within a multinational corporation (MNC), oversea working experience is strongly preferred.
Proven track record of working in an English-speaking work environment (US/EU) – must demonstrate ability to lead scientific discussions in English without language barriers.
工作地点
宁波慈溪市康龙化成杭州湾园区

公司信息
公司介绍
康龙化成(北京)新药技术股份有限公司(股票代码:300759.SZ / 3759.HK)是行业前沿的生命科学研发服务企业。自2003年成立以来,康龙化成一直致力于人才培养和设施建设,为包括小分子、大分子和细胞与基因治疗药物在内的多疗法药物研发打造了一个贯穿药物发现、临床前及临床开发全流程的研发生产服务体系。康龙化成在中国、美国、英国均开展运营,拥有22,000多名员工,向北美、欧洲、日本和中国的合作伙伴提供研发解决方案并与之保持良好的合作关系。(详情请访问公司网站:www.pharmaron.com)
工商信息
企业名称 康龙化成(北京)新药技术股份有限公司
企业类型 股份有限公司
法人代表 楼柏良
经营状态 存续
成立时间 2004-07-01
注册资本 17.78亿元
认证资质
营业执照信息

更新于 2026-06-06 00:35:41


